Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03747887 · ClinicalTrials.gov registry record · NA

Enhancing IEPs of Children With ADHD Using Daily Report Cards

A NA study of Attention Deficit Hyperactivity Disorder, sponsored by State University of New York at Buffalo.

Completed
Registry status
NA
Development phase
211
Enrollment target
1
Study location

NCT03747887: Completed NA study of Attention Deficit Hyperactivity Disorder, sponsored by State University of New York at Buffalo.

NCT03747887 is a NA study of Attention Deficit Hyperactivity Disorder that has completed, run by State University of New York at Buffalo. The registered enrollment target is 211 participants, roughly in line with the 215-participant average among 102 other Attention Deficit Hyperactivity Disorder trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03747887, a NA study of Attention Deficit Hyperactivity Disorder, has completed, sponsored by State University of New York at Buffalo.

COMPLETED
Registry status
NA
Development phase
211 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study are to determine the effectiveness of the daily report card (DRC) approach to supporting children with ADHD in special education in schools compared to a business as usual condition. Children in the study will be randomly assigned to business as usual, or to receive a DRC based on Individualized Education Program goals and objectives, across the school year. All children will have progress carefully monitored across the school year.

Primary Outcome

Frequency count of classroom rule violations collected during three, 30-minute observation periods and averaged.

Conditions Studied

Attention Deficit Hyperactivity Disorder

Interventions

  • BEHAVIORAL Daily Report Card
  • OTHER School as Usual

Study Locations (1)

New York

  • SUNY at Buffalo - Buffalo

Trial Details

FieldValue
Enrollment Target 211 participants
Start Date 2019-01-03
Est. Completion 2023-06-30
Phase NA
State University of New York at Buffalo

243 total trials

What the finished NCT03747887 record still lists

NCT03747887 is an interventional study that assigns participants to a tested intervention. The registered 211 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 215-participant average among 102 other Attention Deficit Hyperactivity Disorder trials with a reported enrollment target.

The record links to 1 condition, with Attention Deficit Hyperactivity Disorder appearing as the primary indexed condition, and to 2 interventions - of which Daily Report Card is the first listed.

NCT03747887 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT03747887 about?

NCT03747887 is a clinical study titled "Enhancing IEPs of Children With ADHD Using Daily Report Cards". The purpose of this study are to determine the effectiveness of the daily report card (DRC) approach to supporting children with ADHD in special education in schools compared to a business as usual condition. Children in the study will be randomly assigned to business as usual, or to receive a DRC b...

What is the current status of trial NCT03747887?

This trial is currently completed. It is a NA study. The enrollment target is 211 participants. The study started on 2019-01-03. Estimated completion is 2023-06-30.

What conditions does trial NCT03747887 study?

This clinical trial studies the following conditions: Attention Deficit Hyperactivity Disorder.

What interventions are being tested in trial NCT03747887?

The interventions under investigation include: Daily Report Card (BEHAVIORAL), School as Usual (OTHER).

Who is sponsoring clinical trial NCT03747887?

This trial is sponsored by State University of New York at Buffalo, which has 243 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03747887 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Attention Deficit Hyperactivity Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03747887's enrollment target sits among peer trials

211 32nd of 102 higher than 71 of 102 other Attention Deficit Hyperactivity Disorder trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Attention Deficit Hyperactivity Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06698796 · 211 participants · Phase 3

    A Study to Understand How the Study Medicine Dazukibart Works in People With Idiopathic Inflammatory Myopathies

  • NCT04228978 · 212 participants · NA

    Promote Weight Loss in Obese Peripheral Artery Disease (PAD) Patients to Prevent Mobility Loss

  • NCT04725721 · 212 participants · NA

    Testing FIRST in Youth Outpatient Psychotherapy

  • NCT06257576 · 212 participants · Phase 3

    Function of Tamsulosin in Older Males Undergoing Surgery with Indwelling Catheter

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Related registry views

Source: ClinicalTrials.gov NCT03747887, the US trial registry maintained by the National Library of Medicine. NCT03747887 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.